Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 21.54 USD 4.46% Market Closed
Market Cap: 285.6m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 39.02 USD with a low forecast of 29.29 USD and a high forecast of 52.5 USD.

ASMB Lowest Forecast
Wall Street Target
29.29 USD
36% Upside
ASMB Average Forecast
Wall Street Target
39.02 USD
81% Upside
ASMB Highest Forecast
Wall Street Target
52.5 USD
144% Upside
Lowest
Price Target
29.29 USD
36% Upside
Average
Price Target
39.02 USD
81% Upside
Highest
Price Target
52.5 USD
144% Upside
Assembly Biosciences Inc Competitors:
Price Targets
OXB
Oxford BioMedica PLC
8% Upside
A
APGE
Apogee Therapeutics Inc
165% Upside
PRTA
Prothena Corporation PLC
52% Upside
M
MDXH
MDxHealth SA
60% Upside
OXB
Oxford BioMedica PLC
8% Upside
A
APGE
Apogee Therapeutics Inc
165% Upside
PRTA
Prothena Corporation PLC
52% Upside
M
MDXH
MDxHealth SA
60% Upside
IDYA
IDEAYA Biosciences Inc
88% Upside
D
688192
Dizal Jiangsu Pharmaceutical Co Ltd
36% Upside
AKBA
Akebia Therapeutics Inc
170% Upside
E
1952
Everest Medicines Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Assembly Biosciences Inc

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 44%.

N/A
Past Growth
44%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
What are analyst estimates?

See Also

Summary
ASMB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ASMB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ASMB stock valuation using valuation multiples.
Wall Street Estimates
ASMB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ASMB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASMB's stock price target?
Price Target
39.02 USD

According to Wall Street analysts, the average 1-year price target for ASMB is 39.02 USD with a low forecast of 29.29 USD and a high forecast of 52.5 USD.

What is Assembly Biosciences Inc's Revenue forecast?
Projected CAGR
44%

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 44%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 283,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.